The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Depression in Schizophrenia: Perspective in the Era of “Atypical” Antipsychotic Agents
Abstract
OBJECTIVE: The author sought to provide a contemporary understanding of depression in schizophrenia and promote a treatment orientation. METHOD: Computer and library-based resources were used to review the literature on depression in schizophrenia. RESULTS: Despite multiple definitions of "depression," a substantial rate of depression has consistently been found in patients with schizophrenia. A differential diagnosis can be used to advance the understanding and treatment of depression in schizophrenia, and changes in response to the advent of atypical antipsychotic agents can be understood in the context of this differential diagnosis paradigm. CONCLUSIONS: Depression is an important co-occurring syndrome in schizophrenia. In at least some schizophrenic patients, the stress-vulnerability model has potential as an integrating concept concerning the relationship between depression and psychosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Dementia Praecox or the Group of Schizophrenias
(1951) · Journal of the American Medical Association · doi:10.1001/jama.1951.02920270079043 · Cited by 4,407
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
Dopamine in schizophrenia: a review and reconceptualization
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.11.1474 · Cited by 2,018
Negative v Positive Schizophrenia: Definition and Validation
Andreasen, N. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070025006 · Cited by 2,012
Vulnerability: A new view of schizophrenia.
Zubin, J., & Spring, B. (1977) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.86.2.103 · Cited by 1,992
Frank, J. (2025) · Johns Hopkins University Press eBooks · doi:10.56021/9781421451374 · Cited by 1,484
Meltzer, H. Y., Matsubara, S., & Lee, J. C. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20710-8 · Cited by 1,349
Risperidone in the treatment of schizophrenia
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.6.825 · Cited by 1,193
Neuroleptics and operant behavior: The anhedonia hypothesis
Wise, R. A. (1982) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00010372 · Cited by 1,016
A Heuristic Vulnerability/Stress Model of Schizophrenic Episodes
Nuechterlein, K. H., & Dawson, M. E. (1984) · Schizophrenia Bulletin · doi:10.1093/schbul/10.2.300 · Cited by 1,004
Hogarty, G. E. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800070019003 · Cited by 917
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.4.457 · Cited by 891
CHOUINARD, G., JONES, B., REMINGTON, G., BLOOM, D., ADDINGTON, D., MacEWAN, G. W., LABELLE, A., BEAUCLAIR, L., & ARNOTT, W. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199302000-00004 · Cited by 876
Olanzapine versus Placebo and Haloperidol
Beasley, C. M., Tollefson, G., Tran, P., Satterlee, W., Sanger, T., & Hamilton, S. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00069-p · Cited by 778
Marder, S. R., Davis, J. M., & Chouinard, G. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n1205 · Cited by 759
Symptoms of Schizophrenia: Methods, Meanings, and Mechanisms
Andreasen, N. C. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950170015003 · Cited by 734
Tran, P. V., Hamilton, S. H., Kuntz, A. J., Potvin, J. H., Andersen, S. W., Beasley, C. J., & Tollefson, G. D. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199710000-00010 · Cited by 715
Endogenomorphic Depression: A Conceptual and Terminological Revision
Klein, D. F. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760160005001 · Cited by 601
Peuskens, J. (1995) · British Journal of Psychiatry · doi:10.1192/bjp.166.6.712 · Cited by 551
THE ACUTE SCHIZOAFFECTIVE PSYCHOSES
Kasanin, J. (1933) · American Journal of Psychiatry · doi:10.1176/ajp.90.1.97 · Cited by 523
A Comparison of Clozapine and Haloperidol in Hospitalized Patients with Refractory Schizophrenia
Rosenheck, R., Cramer, J., Xu, W., Thomas, J., Henderson, W., Frisman, L., Fye, C., & Charney, D. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709183371202 · Cited by 516
Schizophrenics Kill Themselves Too: A Review of Risk Factors for Suicide
Caldwell, C. B., & Gottesman, I. I. (1990) · Schizophrenia Bulletin · doi:10.1093/schbul/16.4.571 · Cited by 514
Treatment of Negative Symptoms
Carpenter, W. T., Heinrichs, D. W., & Alphs, L. D. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.3.440 · Cited by 499
Nicotine Dependence in Schizophrenia: Clinical Phenomena and Laboratory Findings
Dalack, G. W., Healy, D. J., & Meador-Woodruff, J. H. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.11.1490 · Cited by 498
(1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.7.801 · Cited by 455
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.2.183 · Cited by 436
'Akinetic Depression' in Schizophrenia
Van Putten, T. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770330075006 · Cited by 386
Daniel, D. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00090-6 · Cited by 377
Birchwood, M., Mason, R., MacMillan, F., & Healy, J. (1993) · Psychological Medicine · doi:10.1017/s0033291700028488 · Cited by 354
Tandon, R. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810080075010 · Cited by 351
Postpsychotic Depression in Schizophrenia
McGlashan, T. H. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770020065011 · Cited by 344
Five factor model of schizophrenia: replication across samples
Lindenmayer, J. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(94)00041-6 · Cited by 328
Mortality in Current and Former Users of Clozapine
Walker, A. M., Lanza, L. L., Arellano, F., & Rothman, K. J. (1997) · Epidemiology · doi:10.1097/00001648-199710000-00010 · Cited by 328
Symptoms, subtype, and suicidality in patients with schizophrenia spectrum disorders
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.2.199 · Cited by 326
Seeger, T. F., Seymour, P. A., Schmidt, A. W., Zorn, S. H., Schulz, D. W., Lebel, L. A., McLean, S., Guanowsky, V, Howard, H. R., & Lowe, J. A. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12023-5 · Cited by 322
Depression in first-episode schizophrenia
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.11.1643 · Cited by 316
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.4.466 · Cited by 305
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.9.1235 · Cited by 290
Subjective Response to Neuroleptics in Schizophrenia
Awad, A. G. (1993) · Schizophrenia Bulletin · doi:10.1093/schbul/19.3.609 · Cited by 276
Borison, R. L., Arvanitis, L. A., & Milier, B. G. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199604000-00008 · Cited by 268
Keck Jr, P., Buffenstein, A., Ferguson, J., Feighner, J., Jaffe, W., Harrigan, E. P., & Morrissey, M. R. (1998) · Psychopharmacology · doi:10.1007/s002130050755 · Cited by 265
Tollefson, G. D., Sanger, T. M., Lu, Y., & Thieme, M. E. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.3.250 · Cited by 261
Hirsch, S. R., Gaind, R., Rohde, P. D., Stevens, B. C., & Wing, J. K. (1973) · BMJ · doi:10.1136/bmj.1.5854.633 · Cited by 259
Akinesia: A Poorly Recognized Drug-Induced Extrapyramidal Behavioral Disorder
Rifkin, A. (1975) · Archives of General Psychiatry · doi:10.1001/archpsyc.1975.01760230138011 · Cited by 258
Stages of onset of schizophrenic psychosis
(1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.4.420 · Cited by 257
Mechanisms of action of atypical antipsychotic drugs
Deutch, A. Y., Moghaddam, B., Innis, R. B., Krystal, J. H., Aghajanian, G. K., Bunney, B. S., & Charney, D. S. (1991) · Schizophrenia Research · doi:10.1016/0920-9964(91)90030-u · Cited by 253
Sax, K. W., Strakowski, S. M., Keck, P. E., Upadhyaya, V. H., West, S. A., & McElroy, S. L. (1996) · British Journal of Psychiatry · doi:10.1192/bjp.168.1.68 · Cited by 232
'Revealed' Depression and Drug Treatment for Schizophrenia
Knights, A. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780320086010 · Cited by 231
Van Putten, T. (1975) · Comprehensive Psychiatry · doi:10.1016/0010-440x(75)90019-x · Cited by 230
Depression and demoralization: Phenomenologic differences and research perspectives
de Figueiredo, J. M. (1993) · Comprehensive Psychiatry · doi:10.1016/0010-440x(93)90016-w · Cited by 217
Diagnosis of Secondary Depression in Schizophrenia: Implications for DSM-IV
Siris, S. G. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.1.75 · Cited by 217
Self-citationPlatelet serotonin-2 receptor binding sites in depression and suicide
Pandey, G. N., Pandey, S. C., Janicak, P. G., Marks, R. C., & Davis, J. M. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90576-n · Cited by 212
Suicide attempts associated with akathisia
(1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.4.499 · Cited by 201
Are schizophrenia and affective disorder related? A selective literature review
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.1.22 · Cited by 199
Falloon, I., Watt, D. C., & Shepherd, M. (1978) · Psychological Medicine · doi:10.1017/s0033291700006632 · Cited by 196
Silver, H., & Nassar, A. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90279-9 · Cited by 176
When Symptoms Persist: Choosing Among Alternative Somatic Treatments for Schizophrenia
Christison, G. W., Kirch, D. G., & Wyatt, R. J. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.2.217 · Cited by 176
The Nature and Prevalence of Depression in Chronic Schizophrenic In-patients
Barnes, T. R. E., Curson, D. A., Liddle, P. F., & Patel, M. (1989) · British Journal of Psychiatry · doi:10.1192/bjp.154.4.486 · Cited by 166
Side effect profiles of new antipsychotic agents.
Casey, D. E. (1996) · PubMed · Cited by 163
Clozapine: Efficacy and Safety
Buchanan, R. W. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.579 · Cited by 161
Risperidone in the treatment of affective illness and obsessive-compulsive disorder.
Fm, J. (1995) · PubMed · Cited by 158
Severe Depressive Mood Changes Following Slow-release Intramuscular Fluphenazine Injection
de Alarcon, R., & Carney, M. W. P. (1969) · BMJ · doi:10.1136/bmj.3.5670.564 · Cited by 157
Adjunctive Imipramine in the Treatment of Postpsychotic Depression
Siris, S. G. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800180043008 · Cited by 149
Self-citationA placebo-controlled trial of fluoxetine added to neuroleptic in patients with schizophrenia
GOFF, D. C., Amico, E., Sarid‐Segal, O., Midha, K. K., & Hubbard, J. W. (1995) · Psychopharmacology · doi:10.1007/bf02246213 · Cited by 147
Möller, H., Müller, H., Borison, R. L., Schooler, N. R., & Chouinard, G. (1995) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02191543 · Cited by 147
Treatment of Schizoaffective Disorder and Schizophrenia With Mood Symptoms
Levinson, D. F., Umapathy, C., & Musthaq, M. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.8.1138 · Cited by 141
Development and Prediction of Postpsychotic Depression in Neuroleptic-Treated Schizophrenics
Mandel, M. R. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290020051010 · Cited by 138
Prodromal signs and symptoms of schizophrenic relapse.
Subotnik, K. L., & Nuechterlein, K. H. (1988) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.97.4.405 · Cited by 134
Tollefson, G. D., Sanger, T. M., Beasley, C. M., & Trân, P. V. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00093-6 · Cited by 134
Depressive symptoms in schizophrenia: Comprehensive differential diagnosis
Bartels, S. J., & Drake, R. E. (1988) · Comprehensive Psychiatry · doi:10.1016/0010-440x(88)90062-4 · Cited by 131
Postpsychotic depression and negative symptoms: an investigation of syndromal overlap
Siris, S. G., Adan, F., Cohen, M. A., Mandeli, J., Aronson, A. C., & Casey, E. (1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.12.1532 · Cited by 131
Self-citationBermanzohn, P. C., & Siris, S. G. (1992) · Comprehensive Psychiatry · doi:10.1016/0010-440x(92)90045-r · Cited by 130
Self-citationDepression in Schizophrenia: Are Neuroleptics, Akinesia, or Anhedonia Involved?
Harrow, M., Yonan, C. A., Sands, J. R., & Marengo, J. (1994) · Schizophrenia Bulletin · doi:10.1093/schbul/20.2.327 · Cited by 129
Adjunctive fluoxetine in the treatment of negative symptoms in chronic schizophrenic patients
Spina, E., Domenico, P. D., Ruello, C., Longobardo, N., Gitto, C., Ancione, M., Rosa, A. E. D., & Caputi, A. P. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199400940-00007 · Cited by 119
The Pharmacologic Treatment of Neuroleptic-Induced Akathisia
Fleischhacker, W. W., Roth, S. D., & Kane, J. M. (1990) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199002000-00003 · Cited by 119
Major tranquillisers used as antidepressants
Robertson, M. M., & Trimble, M. (1982) · Journal of Affective Disorders · doi:10.1016/0165-0327(82)90002-7 · Cited by 118
Suicide Associated with Akathisia and Depot Fluphenazine Treatment
Shear, M. K., FRANCES, A. J., & WEIDDN, P. (1983) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198308000-00006 · Cited by 113
Antidepressant Usage in Schizophrenia
Plasky, P. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.4.649 · Cited by 111
Are Prophylactic Antiparkinson Drugs Necessary?
Rifkin, A. E. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770280093010 · Cited by 111
Trial of fluoxetine added to neuroleptics for treatment-resistant schizophrenic patients
GOFF, D. C., Brotman, A. W., WAITES, M., & Mccormick, S. (1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.4.492 · Cited by 110
The Significance of Depression in the Prediction of Relapse in Chronic Schizophrenia
Johnson, D. A. W. (1988) · The British Journal of Psychiatry · doi:10.1192/bjp.152.3.320 · Cited by 109
Halstead, S. M., Barnes, T. R. E., & Speller, J. C. (1994) · British Journal of Psychiatry · doi:10.1192/bjp.164.2.177 · Cited by 108
Clozapine in severe mood disorders.
Zarate, C. A., Tohen, M. F., & Baldessarini, R. J. (1995) · PubMed · Cited by 107
Depression in Chronic Schizophrenia
Roy, A., Thompson, R., & Kennedy, S. H. (1983) · The British Journal of Psychiatry · doi:10.1192/bjp.142.5.465 · Cited by 103
Conventional versus atypical neuroleptics: subjective quality of life in schizophrenic patients
Franz, M., Lis, S., Plüddemann, K., et al. (1997) · The British Journal of Psychiatry · doi:10.1192/bjp.170.5.422 · Cited by 102
Keck, P. E., Wilson, D. R., Strakowski, S. M., McElroy, S. L., Kizer, D. L., Balistreri, T. M., Holtman, H. M., & DePRIEST, M. (1995) · PubMed · Cited by 101
The Composition of the Negative Syndrome of Chronic Schizophrenia
Kibel, D., Laffont, I., & Liddle, P. F. (1993) · The British Journal of Psychiatry · doi:10.1192/bjp.162.6.744 · Cited by 98
Prodromal Symptoms in Schizophrenia
MALLA, A. K., & Norman, R. M. G. (1994) · The British Journal of Psychiatry · doi:10.1192/bjp.164.4.487 · Cited by 97
Češková, E., & Švestka, J. (1993) · Pharmacopsychiatry · doi:10.1055/s-2007-1014355 · Cited by 97
Hillert, A., Maier, W., Wetzel, H., & Benkert, O. (1992) · Pharmacopsychiatry · doi:10.1055/s-2007-1014408 · Cited by 94
Correlations over time between dysphoric mood and symptomatology in schizophrenia
Norman, R. M. G., & MALLA, A. K. (1994) · Comprehensive Psychiatry · doi:10.1016/0010-440x(94)90167-8 · Cited by 93
Depression in Chronic Schizophrenia
AGER, H., & MILSTEIN, L. N. (1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.7.870-c · Cited by 92
Maintenance Imipramine Therapy for Secondary Depression in Schizophrenia: A Controlled Trial
Siris, S. G., Bermanzohn, P. C., Mason, S. E., & Shuwall, M. A. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020033003 · Cited by 91
Self-citationTollefson, G., Andersen, S., & Trân, P. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00049-9 · Cited by 88
Silver, H., & Shmugliakov, N. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199806000-00005 · Cited by 88
Citalopram as an adjuvant in chronic schizophrenia: a double‐blind placebo‐controlled study
Salokangas, R. K. R., Saarijãrvi, S., Taiminen, T. J., Kallioniemi, H., Lehto, H., Niemi, H., Tuominen, J., Ahola, V., & Syvälahti, E. K. G. (1996) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1996.tb09844.x · Cited by 84
Pharmacotherapy of Impaired Affect in Recovering Schizophrenic Patients
Hogarty, G. E. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950130029004 · Cited by 83
Quality of Life in Schizophrenia: Insight and Subjective Response to Neuroleptics
Browne, S., Garavan, J., Gervin, M., ROE, M., Larkin, C., & O’Callaghan, E. (1998) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199802000-00002 · Cited by 83
Dysphoric and depressive symptoms in chronic schizophrenia
Hirsch, S. R., Jolley, A., Barnes, T. R. E., Liddle, P. F., Curson, D. A., Patel, A., York, A., Berku, S., & Patel, M. (1989) · Schizophrenia Research · doi:10.1016/0920-9964(89)90002-9 · Cited by 81
The heterogeneity of schizoaffective disorder: implications for treatment
Levitt, J. J., & Tsuang, M. T. (1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.8.926 · Cited by 79
Risperidone in the treatment of schizophrenia: a meta-analysis of randomized controlled trials
Song, F. (1997) · Journal of Psychopharmacology · doi:10.1177/026988119701100116 · Cited by 78
Psychiatric diagnosis and a typology of clinical drug effects
Klein, D. F. (1968) · Psychopharmacology · doi:10.1007/bf00404952 · Cited by 77
Affective Syndromes, Psychotic Features, and Prognosis
Coryell, W. H. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810190051007 · Cited by 75
Should we consider mood disturbance in schizophrenia as an important determinant of quality of life?
Tollefson, G. D., & Andersen, S. W. (1999) · PubMed · Cited by 74
Acute and long-term effectiveness of clozapine in treatment-resistant psychotic depression
Ranjan, R., & Meltzer, H. Y. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00305-3 · Cited by 73
The temporal relationship between depressive and psychotic symptoms in recent-onset schizophrenia
Green, M. F., Nuechterlein, K. H., Ventura, J., & Mintz, J. (1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.2.179 · Cited by 73
Depressive States Occurring During the Neuroleptic Treatment of Schizophrenia
Möller, H. ‐., & Zerssen, D. V. (1982) · Schizophrenia Bulletin · doi:10.1093/schbul/8.1.109 · Cited by 69
Dysphoric mood and symptomatology in schizophrenia
Norman, R. M. G., & MALLA, A. K. (1991) · Psychological Medicine · doi:10.1017/s0033291700029883 · Cited by 67
Aspects of dysphoria and symptoms of schizophrenia
Norman, R. M. G., MALLA, A. K., Cortese, L., & Diaz, F. (1998) · Psychological Medicine · doi:10.1017/s003329179800751x · Cited by 61
The clinical course of depressive symptoms in schizophrenia
Leff, J., Tress, K., & Edwards, B. (1988) · Schizophrenia Research · doi:10.1016/0920-9964(88)90036-9 · Cited by 59
Measurement of Depression and Negative Symptoms in Schizophrenia
Goldman, R., Tandon, R., Liberzon, I., & Greden, J. F. (2010) · Psychopathology · doi:10.1159/000284753 · Cited by 55
Bodkin, J. A., Cohen, B. M., Salomon, M. S., CANNON, S. E., Zornberg, G. L., & Cole, J. O. (1996) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199605000-00005 · Cited by 53
Adjunctive Use of Olanzapine in Mood Disorders: Five Case Reports
Weisler, R. H., Ahearn, E. P., Davidson, J. R. T., & Wallace, C. D. (1997) · Annals of Clinical Psychiatry · doi:10.1023/a:1022312612221 · Cited by 50
The Problem of Post-Psychotic Schizophrenie Depressions and their Pharmacological Induction
Floru, L., Heinrich, K., & Wittek, F. (2017) · International Pharmacopsychiatry · doi:10.1159/000468199 · Cited by 50
The negative symptoms of schizophrenia and the monoamine oxidase inhibitors
Bucci, L. (1987) · Psychopharmacology · doi:10.1007/bf00690936 · Cited by 49
Depression and the experience of psychological deficits in schizophrenia
Liddle, P. F., Barnes, T. R. E., Curson, D. A., & Patel, M. (1993) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1993.tb03450.x · Cited by 49
The frequency of associations between positive and negative symptoms and dysphoria in schizophrenia
Lysaker, P. H., Bell, M. D., BIOTY, S. M., & Zito, W. (1995) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(95)90105-1 · Cited by 47
Effect of neuroleptic treatment on depressive symptoms in acute schizophrenic episodes
KRAKOWSKI, M. I., Czobor, P., & Volavka, J. (1997) · Psychiatry Research · doi:10.1016/s0165-1781(97)03076-x · Cited by 47
The expanding indications for clozapine.
Young, C. R., Longhurst, J. G., Jr. Bowers Malcolm, B., & Mazure, C. M. (1997) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.5.3.216 · Cited by 46
Lindenmayer, J., Grochowski, S., & Kay, S. R. (1991) · Comprehensive Psychiatry · doi:10.1016/0010-440x(91)90032-8 · Cited by 45
Adjunctive Antidepressant Drug Therapies in the Treatment of Negative Symptoms of Schizophrenia
Evins, A. E., & GOFF, D. C. (1996) · CNS Drugs · doi:10.2165/00023210-199606020-00005 · Cited by 44
The new antipsychotics, and their potential for early intervention in schizophrenia
Waddington, J. L., Scully, P. J., & O’Callaghan, E. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00115-1 · Cited by 42
Serotonin, dopamine and their interactions in schizophrenia
Kahn, R. S., & Davidson, M. (1993) · Psychopharmacology · doi:10.1007/bf02245002 · Cited by 41
Depressive syndromes in schizophrenic patients after discharge from hospital
Bandelow, B., Müller, P., Gäebel, W., Köpcke, W., Linden, M., Müller-Spahn, F., Pietzcker, A., Reischies, F. M., Tegeler, J., & ANI Study Group Berlin, D. (1990) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02189981 · Cited by 40
Lithium Combined with Haloperidol in Schizophrenic Patients
Lerner, Y., Mintzer, Y., & Schestatzky, M. (1988) · The British Journal of Psychiatry · doi:10.1192/bjp.153.3.359 · Cited by 40
Depressions in schizophrenia: Some observations on prevalence, etiology, and treatment
Johnson, D. A. W. (1981) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1981.tb02466.x · Cited by 32
Depressive symptoms in acute schizophrenic inpatients
Nakaya, M., Ohmori, K., Komahashi, T., & Suwa, H. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00014-5 · Cited by 31
The use of monoamine oxidase inhibitors in schizophrenia.
Brenner, R., & Shopsin, B. (1980) · PubMed · Cited by 29
Müller, M. J., & Wetzel, H. (1998) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(98)00029-6 · Cited by 28
Negative Symptomatology in Schizophrenic Outpatients
Kuck, J., Zisook, S., Moranville, J., Heaton, R. K., & BRAFF, D. L. (1992) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199208000-00006 · Cited by 27
L-Deprenyl in treating negative symptoms of schizophrenia
Perényi, A., Goswami, U., Frecska, E., Arató, M., & Béla, Á. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90082-e · Cited by 19
Fluphenazine decanoate dose and severity of depression in patients with post-psychotic depression
Siris, S. G., Strahan, A., Mandeli, J., Casey, E., & Cooper, T. B. (1988) · Schizophrenia Research · doi:10.1016/0920-9964(88)90037-0 · Cited by 19
Self-citationDepressive symptoms and schizophrenia a psychopharmacological approach.
Mc, M., Bravin, S., Fabiano, L. R. F. L. R., Vanni, S., Boscati, L., & INVERNIZZI, G. (1995) · PubMed · Cited by 15
Cited by
Psychiatric Comorbidities and Schizophrenia
Buckley, P. F., Miller, B. J., Lehrer, D. S., & Castle, D. J. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn135 · Cited by 1,121
Galletly, C., Castle, D., Dark, F., Humberstone, V., Jablensky, A., Killackey, E., Kulkarni, J., McGorry, P., Nielssen, O., & Tran, N. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416641195 · Cited by 877
Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
“Finally, in patients who are relatively clinically stable, it is possible that the onset of depressive symptoms is a prodrome of psychotic relapse (Siris, 2000).”
BackgroundInfluentialResearch Domain Criteria: cognitive systems, neural circuits, and dimensions of behavior
Morris, S. E., & Cuthbert, B. N. (2012) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2012.14.1/smorris · Cited by 638
Barnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Metadata
- Authors
- Siris, S. G.
- Venue
- American Journal of Psychiatry
- Published
- 2000-09-01
- Volume
- 157
- Issue
- 9
- Pages
- 1379-1389
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W1999320625
- Cited by
- 427
- References
- 135
- FWCI
- 8.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.